Neuroscientists and neurosurgeons at the EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthetic intended to correct walking disorders associated with Parkinson’s disease. In a study published in Nature Medicine, the scientists set out in detail the process of developing the neuroprosthetic that has allowed a first patient with Parkinson’s to be treated, enabling him to walk comfortably, confidently and without falling.
Read MoreA complete spinal cord injury leads to irreversible paralysis. Scientists at .NeuroRestore report in Science that they have developed a gene therapy that was proven in mice to stimulate nerve regrowth across such injuries and guide nerves to reconnect to their natural targets below the injuries in order to restore motor function.
Read MoreNeuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report in the journal Nature that they have re-established the communication between the brain and spinal cord with a wireless digital bridge, allowing a paralyzed person to walk again naturally.
Read MoreA new study by scientists at the .NeuroRestore research center hasidentified the type of neuron that is activated and remodeled by spinalcord stimulation, allowing patients to stand up, walk and rebuild theirmuscles – thus improving their quality of life. This discovery, made innine patients, marks a fundamental, clinical breakthrough. The study waspublished today in Nature.
Read MoreMost patients with advanced Parkinson's disease develop disturbances of gait and balance, which severely affect their everyday mobility, independence, and quality of life. Using a last generation deep brain stimulation implant able to simultaneously stimulate and record the brain, we identified the neural activity patterns that correlate with normal and pathological gait. These results open new avenues for the development of adaptive neuromodulation therapies that can target gait deficits and prevent falls in real-time.
Read MoreA patient suffering from a debilitating neurodegenerative disease was able to get up and walk again after being bedridden for over a year, thanks to an innovative system developed by a team of scientists at the NeuroRestore research center headed by Jocelyne Bloch, a neurosurgeon at Lausanne University Hospital (CHUV) and Professor at University of Lausanne UNIL, and Grégoire Courtine, an EPFL professor in neuroscience. Their system includes electronics implanted directly on the spinal cord to reactivate the neurons that regulate blood pressure, thereby preventing the patient from losing consciousness every time she is in an upright position.
Read MoreA system developed by Grégoire Courtine and Jocelyne Bloch now enables patients with a complete spinal cord injury to stand, walk and even perform recreational activities like swimming, cycling and canoeing.
Read MoreA revolutionary implant developed at EPFL allows neuroscientists to activate or inhibit specific spinal-cord neurons by applying light at a specific wavelength. It will give researchers insight into how the nervous system works and the chance to develop new ways of treating neurological disorders.
Read MoreSpinal cord injuries disrupt the mechanism by which our bodies regulate blood pressure. A team of Swiss and Canadian scientists have developed a treatment that allows patients to regain control of their blood pressure, using targeted electrical spinal-cord stimulation. No medication is required. The team’s findings were published today in Nature.
Read MoreResearchers at the Brain Mind Institute, Center for Neuroprosthetics and NeuroRestore won the second prize at the Annual BCI Award 2020for the world’s most outstanding and innovative research in the field Brain-Computer Interfaces.
Read MoreGrégoire Courtine, a neuroscientist and EPFL researcher in Switzerland, has been awarded the IET A F Harvey Engineering Research Prize – the most valuable prize of £350,000 (CHF 420,000) given out by the Institution of Engineering and Technology (IET). Courtine will use the funding to further his research on spinal cord regeneration. Several paraplegics have already regained the use of their legs thanks to his work.
Read MoreLa Fondation Defitech s’associe à l’EPFL, au CHUV et à l’UNIL pour créer un nouveau centre développant des approches technologiques chirurgicales innovantes pour traiter les patients souffrant d'atteintes neurologiques et motrices
Read MoreThe Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again. Their aim is also to develop new neurosurgical treatments for people suffering from Parkinson’s disease or from neurological disorders following a head injury or stroke.
Read MoreUne nouvelle plateforme scientifique travaillant sur des approches visant au rétablissement des fonctions neurologiques a vu le jour. "NeuroRestore" réunit des ingénieurs, médecins et chercheurs de l'EPFL, du CHUV, de l'UNIL avec le soutien de la fondation Defitech.
Read MoreEPFL's School of Life Sciences congratulates and welcomes the following Professors:
Read MoreThe EPFL researcher is one of five laureates of the 2019 Rolex Awards for Enterprise. The laureates will receive financial support for their innovative projects that contribute to the common good.
Read More
